Related Experiment Videos
Intravenous immunoglobulin in pregnancy
Obstetrics and Gynecology
|September 1, 1985
Summary
During pregnancy, a woman with variable hypogammaglobulinemia received intravenous immunoglobulin therapy. This treatment successfully transferred immunoglobulin G subclasses to the fetus, supporting immune development.
Area of Science:
- Immunology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Variable hypogammaglobulinemia poses risks during pregnancy.
- Intravenous immunoglobulin (IVIG) is a potential therapeutic option.
- Understanding fetal transfer of immunoglobulins is crucial for neonatal health.
Observation:
- A pregnant woman diagnosed with variable hypogammaglobulinemia underwent treatment.
- The treatment involved the administration of an intravenous immunoglobulin preparation.
- Specific immunoglobulin G subclasses were monitored for transfer.
Findings:
- All tested immunoglobulin G subclasses (IgG1, IgG2, and IgG3) were successfully transferred from mother to fetus.
- The IVIG preparation facilitated the passage of these critical immune components across the placenta.
Implications:
- Maternal IVIG therapy can provide passive immunity to the fetus.
- This transfer may help protect newborns from infections, especially those born to mothers with immune deficiencies.
- Further research can explore optimal dosing and timing for IVIG during pregnancy.